DK1117421T3 - Hidtil ukendte fremgangsmåder til terapuetisk vaccination - Google Patents

Hidtil ukendte fremgangsmåder til terapuetisk vaccination

Info

Publication number
DK1117421T3
DK1117421T3 DK99945967T DK99945967T DK1117421T3 DK 1117421 T3 DK1117421 T3 DK 1117421T3 DK 99945967 T DK99945967 T DK 99945967T DK 99945967 T DK99945967 T DK 99945967T DK 1117421 T3 DK1117421 T3 DK 1117421T3
Authority
DK
Denmark
Prior art keywords
new methods
therapeutic vaccination
vaccination
therapeutic
new
Prior art date
Application number
DK99945967T
Other languages
English (en)
Inventor
Dana Leach
Peter Birk Rasmussen
Lucilla Steinaa
Klaus Gregorius Nielsen
Jesper Haaning
Iben Dalum
Gunilla Karlsson
Soren Mouritsen
Anand Gautam
Original Assignee
Pharmexa As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmexa As filed Critical Pharmexa As
Priority claimed from EP99945967.0A external-priority patent/EP1117421B2/en
Application granted granted Critical
Publication of DK1117421T3 publication Critical patent/DK1117421T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A61K40/4203—Receptors for growth factors
    • A61K40/4205—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4225—Growth factors
    • A61K40/4227—Fibroblast growth factors [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4274—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; Prostatic acid phosphatase [PAP]; Prostate-specific G-protein-coupled receptor [PSGR]
    • A61K40/4276—Prostate specific membrane antigen [PSMA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/58—Prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99945967T 1998-10-05 1999-10-05 Hidtil ukendte fremgangsmåder til terapuetisk vaccination DK1117421T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801261 1998-10-05
EP99945967.0A EP1117421B2 (en) 1998-10-05 1999-10-05 Methods for therapeutic vaccination

Publications (1)

Publication Number Publication Date
DK1117421T3 true DK1117421T3 (da) 2004-11-01

Family

ID=27675502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99945967T DK1117421T3 (da) 1998-10-05 1999-10-05 Hidtil ukendte fremgangsmåder til terapuetisk vaccination

Country Status (5)

Country Link
EP (1) EP1502602A3 (da)
DK (1) DK1117421T3 (da)
ID (1) ID28387A (da)
SI (1) SI1117421T1 (da)
ZA (1) ZA200102603B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008040759A1 (en) * 2006-10-03 2008-04-10 Pharmexa A/S Method for down-regulation of cripto
CN103091499B (zh) * 2013-01-23 2015-07-08 三峡大学 一种肿瘤标志物钙网蛋白检测试剂盒的制备及应用
CN112010960A (zh) * 2020-09-10 2020-12-01 热休(厦门)细胞生物科技有限公司 一种肿瘤抗原复合物体外致敏dc、t细胞获得肿瘤特异性杀伤细胞ctl及其制备方法
CN116747298B (zh) * 2023-08-09 2024-01-02 成都新诺明生物科技有限公司 一种水痘-带状疱疹病毒疫苗及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
AUPO390396A0 (en) * 1996-11-29 1996-12-19 Csl Limited Novel promiscuous T helper cell epitopes
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
PT1053325E (pt) * 1998-02-05 2006-05-31 Glaxosmithkline Biolog Sa Derivados de antigenios associados a tumores da familia mage e, sequencias de acidos nucleicos que os codificam, utilizados para a preparacao de proteinas de fusao e de composicoes para vacinacao.

Also Published As

Publication number Publication date
SI1117421T1 (en) 2004-12-31
ZA200102603B (en) 2002-09-30
EP1502602A3 (en) 2006-05-17
ID28387A (id) 2001-05-17
EP1502602A2 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
ID27841A (id) Turunan-turunan biaril terapeutik
HUP0103976A3 (en) Novel methods for therapeutic vaccination
EE200100370A (et) Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid
NO20040353L (no) Ny terapeutsk metode
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO20014950L (no) Nye behandlingsmetoder
ID27191A (id) Metode untuk pengobatan insomnia
ID18679A (id) Penggunaan terapi lanjutan
NO986177L (no) FremgangsmÕte for fremstilling av terapeutisk DNA
IS5742A (is) Aðferð til genalækninga
EE04154B1 (et) Omeprasooli valmistamise meetod
IS6172A (is) Notkun melatoníns til lækninga
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DK1117421T3 (da) Hidtil ukendte fremgangsmåder til terapuetisk vaccination
ID24922A (id) Terapi kombinasi untuk pengobatan aids
IT1283040B1 (it) Procedimento per la preparazione di acqua ossigenata
ID27014A (id) Metode yang lebih baik untuk pembuatan turunan-turunan norbenzomorfana yang bermanfaat secara farmasi
FI974235A0 (fi) Ny bestaemningsmetod
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
DK1047668T3 (da) Triazepinoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia